Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Oct 2020 for Aimmune Therapeutics, Inc., €230k.
Insider track record
Disclosed buys
0
Disclosed sells
0
Signal history
No signal scores available.
Gregory Behar: trading record in brief
Gregory Behar appears in our data through filings on Aimmune Therapeutics, Inc. shares, published by SEC (Form 4). Over a trading history stretching from 23 May 2018 to 13 October 2020, the count stands at 5 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 14 October 2020 came the latest disclosure, a transaction for €230k in Aimmune Therapeutics, Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. For comparison, the SEC allows two business days to file a Form 4. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Gregory Behar
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
7,840 shares@ US$34.50100.0% of flowCommon Stock, $0.0001 par valueSEC:0000899243-20-028179:1
10,192 shares0Common Stock, $0.0001 par valueSEC:0000899243-20-028179:0
7,840 shares0Common Stock, $0.0001 par valueSEC:0000899243-20-014619:0
6,442 shares0Common Stock, $0.0001 par valueSEC:0000899243-19-014971:0
3,750 shares0Common Stock, $0.0001 par valueSEC:0000899243-18-013930:0
5 of 5 declarations
